speb/financial-data huggingface dataset:
TARS balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 1306000.00
TARS balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 114000.00
TARS balance_sheet (annual, 2021-12-31) — Financial Assets: 663000.00
TARS cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: 987000.00
TARS cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 70000.00
TARS income_statement (annual, 2021-12-31) — Gain On Sale Of Security: -1578000.00
TARS income_statement (annual, 2021-12-31) — General And Administrative Expense: 25397000.00
TARS balance_sheet (annual, 2021-12-31) — Income Tax Payable: 55000.00
TARS balance_sheet (annual, 2021-12-31) — Interest Payable: 0.00
TARS balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 585000.00
TARS cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: -2000.00
TARS cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -303000.00
TARS cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 0.00
TARS balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 71000.00
TARS cash_flow (annual, 2021-12-31) — Operating Gains Losses: 1055000.00
TARS income_statement (annual, 2021-12-31) — Other Gand A: 25397000.00
TARS balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 56000.00
TARS cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 0.00
TARS balance_sheet (annual, 2021-12-31) — Restricted Cash: 0.00
TARS balance_sheet (annual, 2021-12-31) — Taxes Receivable: 90000.00
TARS balance_sheet (annual, 2021-12-31) — Total Tax Payable: 55000.00
TARS balance_sheet (annual, 2021-12-31) — Treasury Shares Number: 27843.00
TARS income_statement (annual, 2022-12-31) — +Operating Expense: 87573000.00
TARS income_statement (annual, 2022-12-31) — +Total Revenue: 25816000.00
TARS balance_sheet (annual, 2022-12-31) — Accounts Payable: 5498000.00
TARS balance_sheet (annual, 2022-12-31) — Accounts Receivable: 0.00
TARS balance_sheet (annual, 2022-12-31) — Accrued Interest Receivable: 178000.00
TARS balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -546000.00
TARS balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 301732000.00
TARS cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 0.00
TARS cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 0.00
TARS cash_flow (annual, 2022-12-31) — Amortization Of Securities: -1316000.00
TARS income_statement (annual, 2022-12-31) — Basic Average Shares: 24619700.00
TARS income_statement (annual, 2022-12-31) — Basic EPS: -2.52
TARS cash_flow (annual, 2022-12-31) — Beginning Cash Position: 171332000.00
TARS cash_flow (annual, 2022-12-31) — Capital Expenditure: -506000.00
TARS balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 721000.00
TARS balance_sheet (annual, 2022-12-31) — Capital Stock: 5000.00
TARS balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 71660000.00
TARS balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 217026000.00
TARS balance_sheet (annual, 2022-12-31) — Cash Equivalents: 71660000.00
TARS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 93987000.00
TARS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -144629000.00
TARS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -49030000.00
TARS cash_flow (annual, 2022-12-31) — Change In Account Payable: 821000.00
TARS cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 2721000.00
TARS cash_flow (annual, 2022-12-31) — Change In Inventory: 0.00
TARS cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -215000.00
TARS cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -67000.00
TARS cash_flow (annual, 2022-12-31) — Change In Payable: 821000.00
TARS cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 3542000.00
TARS cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -721000.00
TARS cash_flow (annual, 2022-12-31) — Change In Receivables: -3490000.00
TARS cash_flow (annual, 2022-12-31) — Change In Working Capital: -951000.00
TARS cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 0.00
TARS cash_flow (annual, 2022-12-31) — Changes In Cash: -99672000.00
TARS balance_sheet (annual, 2022-12-31) — Common Stock: 5000.00
TARS balance_sheet (annual, 2022-12-31) — Common Stock Equity: 192900000.00
TARS cash_flow (annual, 2022-12-31) — Common Stock Issuance: 74352000.00
TARS income_statement (annual, 2022-12-31) — Cost Of Revenue: 955000.00
TARS balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 9210000.00
TARS balance_sheet (annual, 2022-12-31) — Current Assets: 225375000.00
TARS balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 721000.00
TARS balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 721000.00
TARS balance_sheet (annual, 2022-12-31) — Current Liabilities: 15429000.00
TARS cash_flow (annual, 2022-12-31) — Depreciation: 326000.00
TARS cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 326000.00
TARS cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 326000.00
TARS balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 48000.00
TARS income_statement (annual, 2022-12-31) — Diluted Average Shares: 24619700.00
TARS income_statement (annual, 2022-12-31) — Diluted EPS: -2.52
TARS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -62091000.00
TARS income_statement (annual, 2022-12-31) — EBIT: -60031000.00
TARS income_statement (annual, 2022-12-31) — EBITDA: -59705000.00
TARS cash_flow (annual, 2022-12-31) — End Cash Position: 71660000.00
TARS balance_sheet (annual, 2022-12-31) — Financial Assets: 108000.00
TARS cash_flow (annual, 2022-12-31) — Financing Cash Flow: 93987000.00
TARS cash_flow (annual, 2022-12-31) — Free Cash Flow: -49536000.00
TARS cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 501000.00
TARS cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
TARS income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -769000.00
TARS balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -74000.00
TARS income_statement (annual, 2022-12-31) — General And Administrative Expense: 44949000.00
TARS balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 0.00
TARS balance_sheet (annual, 2022-12-31) — Gross PPE: 2078000.00
TARS income_statement (annual, 2022-12-31) — Gross Profit: 24861000.00
TARS balance_sheet (annual, 2022-12-31) — Income Tax Payable: 14000.00
TARS income_statement (annual, 2022-12-31) — Interest Expense: 2064000.00
TARS income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 2064000.00
TARS income_statement (annual, 2022-12-31) — Interest Income: 3499000.00
TARS income_statement (annual, 2022-12-31) — Interest Income Non Operating: 3499000.00
TARS cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 1675000.00
TARS balance_sheet (annual, 2022-12-31) — Interest Payable: 215000.00
TARS balance_sheet (annual, 2022-12-31) — Inventory: 0.00
TARS balance_sheet (annual, 2022-12-31) — Invested Capital: 212334000.00
TARS cash_flow (annual, 2022-12-31) — Investing Cash Flow: -144629000.00
TARS balance_sheet (annual, 2022-12-31) — Investments And Advances: 371000.00
TARS cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 74352000.00
TARS cash_flow (annual, 2022-12-31) — Issuance Of Debt: 20000000.00
TARS balance_sheet (annual, 2022-12-31) — Leases: 425000.00
TARS balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 52000.00
TARS balance_sheet (annual, 2022-12-31) — Long Term Debt: 19434000.00
TARS balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 19434000.00
TARS cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 20000000.00
TARS balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 911000.00
TARS cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 74352000.00
TARS cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 1000.00
TARS income_statement (annual, 2022-12-31) — Net Income: -62091000.00
TARS income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -62091000.00
TARS income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -62091000.00
TARS income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -62091000.00
TARS income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -62091000.00
TARS cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -62091000.00
TARS income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -62091000.00
TARS cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: 0.00
TARS income_statement (annual, 2022-12-31) — Net Interest Income: 1300000.00
TARS cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -144123000.00
TARS cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 20000000.00
TARS cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 20000000.00
TARS income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 1300000.00
TARS cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -950000.00
TARS balance_sheet (annual, 2022-12-31) — Net PPE: 1532000.00
TARS cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -506000.00
TARS balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 192900000.00
TARS balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 82000.00
TARS income_statement (annual, 2022-12-31) — Normalized EBITDA: -58936000.00
TARS income_statement (annual, 2022-12-31) — Normalized Income: -61322049.54
TARS cash_flow (annual, 2022-12-31) — Operating Cash Flow: -49030000.00
TARS cash_flow (annual, 2022-12-31) — Operating Gains Losses: 501000.00
TARS income_statement (annual, 2022-12-31) — Operating Income: -62712000.00
TARS income_statement (annual, 2022-12-31) — Operating Revenue: 25816000.00
TARS balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 26727458.00
TARS balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -74000.00
TARS income_statement (annual, 2022-12-31) — Other Gand A: 44949000.00
TARS income_statement (annual, 2022-12-31) — Other Income Expense: -683000.00
TARS cash_flow (annual, 2022-12-31) — Other Non Cash Items: 773000.00
TARS balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 585000.00
TARS balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 100000.00
TARS income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 86000.00
TARS balance_sheet (annual, 2022-12-31) — Other Properties: 742000.00
TARS balance_sheet (annual, 2022-12-31) — Other Receivables: 3582000.00
TARS balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 145366000.00
TARS balance_sheet (annual, 2022-12-31) — Payables: 5498000.00
TARS balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 14708000.00
TARS balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 0.00
TARS balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
TARS balance_sheet (annual, 2022-12-31) — Prepaid Assets: 4767000.00
TARS income_statement (annual, 2022-12-31) — Pretax Income: -62095000.00
TARS cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 585000.00
TARS balance_sheet (annual, 2022-12-31) — Properties: 0.00
TARS cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: 0.00
TARS cash_flow (annual, 2022-12-31) — Purchase Of Investment: -149438000.00
TARS cash_flow (annual, 2022-12-31) — Purchase Of PPE: -506000.00
TARS balance_sheet (annual, 2022-12-31) — Receivables: 3582000.00
TARS income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 955000.00
TARS income_statement (annual, 2022-12-31) — Reconciled Depreciation: 326000.00
TARS income_statement (annual, 2022-12-31) — Research And Development: 42624000.00
TARS balance_sheet (annual, 2022-12-31) — Retained Earnings: -108763000.00
TARS cash_flow (annual, 2022-12-31) — Sale Of Investment: 5315000.00
TARS income_statement (annual, 2022-12-31) — Selling General And Administration: 44949000.00
TARS balance_sheet (annual, 2022-12-31) — Share Issued: 26727458.00
TARS income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
TARS cash_flow (annual, 2022-12-31) — Stock Based Compensation: 13460000.00
TARS balance_sheet (annual, 2022-12-31) — Stockholders Equity: 192900000.00
TARS balance_sheet (annual, 2022-12-31) — Tangible Book Value: 192900000.00
TARS income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -49.54
TARS income_statement (annual, 2022-12-31) — Tax Provision: -4000.00
TARS income_statement (annual, 2022-12-31) — Tax Rate For Calcs:
TARS balance_sheet (annual, 2022-12-31) — Taxes Receivable: 126000.00
TARS balance_sheet (annual, 2022-12-31) — Total Assets: 227863000.00
TARS balance_sheet (annual, 2022-12-31) — Total Capitalization: 212334000.00
TARS balance_sheet (annual, 2022-12-31) — Total Debt: 20155000.00
TARS balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 192900000.00
TARS income_statement (annual, 2022-12-31) — Total Expenses: 88528000.00
TARS balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 34963000.00
TARS balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 2488000.00
TARS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 19534000.00
TARS income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -62712000.00
TARS income_statement (annual, 2022-12-31) — Total Other Finance Cost: 135000.00
TARS balance_sheet (annual, 2022-12-31) — Total Tax Payable: 14000.00
TARS income_statement (annual, 2022-12-31) — Total Unusual Items: -769000.00
TARS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -769000.00
TARS cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 268000.00
TARS balance_sheet (annual, 2022-12-31) — Working Capital: 209946000.00
TARS income_statement (annual, 2023-12-31) — +Operating Expense: 159012000.00
TARS income_statement (annual, 2023-12-31) — +Total Revenue: 17447000.00
TARS balance_sheet (annual, 2023-12-31) — Accounts Payable: 17772000.00
TARS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 16621000.00
TARS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1290000.00
TARS balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 441641000.00
TARS cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 133000.00
TARS cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 133000.00
TARS cash_flow (annual, 2023-12-31) — Amortization Of Securities: -3163000.00
TARS income_statement (annual, 2023-12-31) — Basic Average Shares: 29383276.00
TARS income_statement (annual, 2023-12-31) — Basic EPS: -4.62
TARS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 71660000.00
TARS cash_flow (annual, 2023-12-31) — Capital Expenditure: -5502000.00
TARS balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 398000.00
TARS balance_sheet (annual, 2023-12-31) — Capital Stock: 5000.00
TARS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 224947000.00
TARS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 227442000.00
TARS balance_sheet (annual, 2023-12-31) — Cash Equivalents: 224947000.00
TARS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 130176000.00
TARS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 140604000.00
TARS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -117493000.00
TARS cash_flow (annual, 2023-12-31) — Change In Account Payable: 4537000.00
TARS cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 7726000.00
TARS cash_flow (annual, 2023-12-31) — Change In Inventory: -3107000.00
TARS cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -718000.00
TARS cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 8888000.00
TARS cash_flow (annual, 2023-12-31) — Change In Payable: 4537000.00
TARS cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 12263000.00
TARS cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -2889000.00
TARS cash_flow (annual, 2023-12-31) — Change In Receivables: -14131000.00
TARS cash_flow (annual, 2023-12-31) — Change In Working Capital: 306000.00
TARS cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -16621000.00
TARS cash_flow (annual, 2023-12-31) — Changes In Cash: 153287000.00
TARS balance_sheet (annual, 2023-12-31) — Common Stock: 5000.00
TARS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 196988000.00
TARS cash_flow (annual, 2023-12-31) — Common Stock Issuance: 118599000.00
TARS income_statement (annual, 2023-12-31) — Cost Of Revenue: 1593000.00
TARS balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 18112000.00
TARS balance_sheet (annual, 2023-12-31) — Current Assets: 256131000.00
TARS balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 398000.00
TARS balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 398000.00
TARS balance_sheet (annual, 2023-12-31) — Current Liabilities: 36936000.00
TARS cash_flow (annual, 2023-12-31) — Depreciation: 744000.00
TARS cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 877000.00
TARS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 877000.00
TARS income_statement (annual, 2023-12-31) — Diluted Average Shares: 29383276.00
TARS income_statement (annual, 2023-12-31) — Diluted EPS: -4.62
TARS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -135893000.00
TARS income_statement (annual, 2023-12-31) — EBIT: -132668000.00
TARS income_statement (annual, 2023-12-31) — EBITDA: -131791000.00
TARS cash_flow (annual, 2023-12-31) — End Cash Position: 224947000.00
TARS cash_flow (annual, 2023-12-31) — Financing Cash Flow: 130176000.00
TARS balance_sheet (annual, 2023-12-31) — Finished Goods: 182000.00
TARS cash_flow (annual, 2023-12-31) — Free Cash Flow: -122995000.00
TARS cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -117000.00
TARS income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 376000.00
TARS balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -2000.00
TARS balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 3867000.00
TARS balance_sheet (annual, 2023-12-31) — Gross PPE: 4638000.00
TARS income_statement (annual, 2023-12-31) — Gross Profit: 15854000.00
TARS income_statement (annual, 2023-12-31) — Interest Expense: 3225000.00
TARS income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 3225000.00
TARS income_statement (annual, 2023-12-31) — Interest Income: 10337000.00
TARS income_statement (annual, 2023-12-31) — Interest Income Non Operating: 10337000.00
TARS cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 2880000.00
TARS balance_sheet (annual, 2023-12-31) — Inventory: 3107000.00
TARS balance_sheet (annual, 2023-12-31) — Invested Capital: 226807000.00
TARS cash_flow (annual, 2023-12-31) — Investing Cash Flow: 140604000.00
TARS balance_sheet (annual, 2023-12-31) — Investments And Advances: 631000.00
TARS cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 118599000.00
TARS cash_flow (annual, 2023-12-31) — Issuance Of Debt: 10000000.00
TARS balance_sheet (annual, 2023-12-31) — Leases: 680000.00
TARS balance_sheet (annual, 2023-12-31) — Long Term Debt: 29819000.00
TARS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 29819000.00
TARS cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 10000000.00
TARS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1911000.00
TARS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 118599000.00
TARS cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
TARS income_statement (annual, 2023-12-31) — Net Income: -135893000.00
TARS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -135893000.00
TARS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -135893000.00
TARS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -135893000.00
TARS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -135893000.00
TARS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -135893000.00
TARS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -135893000.00
TARS cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -4000000.00
TARS income_statement (annual, 2023-12-31) — Net Interest Income: 6991000.00
TARS cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 146106000.00
TARS cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 10000000.00
TARS cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 10000000.00
TARS income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 6991000.00
TARS balance_sheet (annual, 2023-12-31) — Net PPE: 3348000.00
TARS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1502000.00
TARS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 193121000.00
TARS income_statement (annual, 2023-12-31) — Normalized EBITDA: -131791000.00
TARS income_statement (annual, 2023-12-31) — Normalized Income: -135893000.00
TARS cash_flow (annual, 2023-12-31) — Operating Cash Flow: -117493000.00
TARS cash_flow (annual, 2023-12-31) — Operating Gains Losses: -117000.00
TARS income_statement (annual, 2023-12-31) — Operating Income: -143158000.00
TARS income_statement (annual, 2023-12-31) — Operating Revenue: 17447000.00
TARS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 34211190.00
TARS balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -2000.00
TARS income_statement (annual, 2023-12-31) — Other Income Expense: 274000.00
TARS cash_flow (annual, 2023-12-31) — Other Non Cash Items: 926000.00
TARS balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1514000.00
TARS balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1748000.00
TARS income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 274000.00
TARS balance_sheet (annual, 2023-12-31) — Other Payable: 654000.00
TARS balance_sheet (annual, 2023-12-31) — Other Properties: 2047000.00
TARS balance_sheet (annual, 2023-12-31) — Other Receivables: 1093000.00
TARS balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 2495000.00
TARS balance_sheet (annual, 2023-12-31) — Payables: 18426000.00
TARS balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 36538000.00
TARS balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
TARS balance_sheet (annual, 2023-12-31) — Prepaid Assets: 7868000.00
TARS income_statement (annual, 2023-12-31) — Pretax Income: -135893000.00
TARS cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 1577000.00
TARS balance_sheet (annual, 2023-12-31) — Properties: 0.00
TARS cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -4000000.00
TARS cash_flow (annual, 2023-12-31) — Purchase Of Investment: -28664000.00
TARS cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1502000.00
TARS balance_sheet (annual, 2023-12-31) — Raw Materials: 2533000.00
TARS balance_sheet (annual, 2023-12-31) — Receivables: 17714000.00
TARS income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1593000.00
TARS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 877000.00
TARS income_statement (annual, 2023-12-31) — Research And Development: 50312000.00
TARS balance_sheet (annual, 2023-12-31) — Retained Earnings: -244656000.00
TARS cash_flow (annual, 2023-12-31) — Sale Of Investment: 174770000.00
TARS income_statement (annual, 2023-12-31) — Selling General And Administration: 108700000.00
TARS balance_sheet (annual, 2023-12-31) — Share Issued: 34211190.00
TARS income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
TARS cash_flow (annual, 2023-12-31) — Stock Based Compensation: 19830000.00
TARS balance_sheet (annual, 2023-12-31) — Stockholders Equity: 196988000.00
TARS balance_sheet (annual, 2023-12-31) — Tangible Book Value: 193121000.00
TARS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
TARS income_statement (annual, 2023-12-31) — Tax Provision: 0.00
TARS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
TARS balance_sheet (annual, 2023-12-31) — Total Assets: 265491000.00
TARS balance_sheet (annual, 2023-12-31) — Total Capitalization: 226807000.00
TARS balance_sheet (annual, 2023-12-31) — Total Debt: 30217000.00
TARS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 196988000.00
TARS income_statement (annual, 2023-12-31) — Total Expenses: 160605000.00
TARS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 68503000.00
TARS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 9360000.00
TARS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 31567000.00
TARS income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -143158000.00
TARS income_statement (annual, 2023-12-31) — Total Other Finance Cost: 121000.00
TARS income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
TARS income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
TARS cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -259000.00
TARS balance_sheet (annual, 2023-12-31) — Work In Process: 392000.00
TARS balance_sheet (annual, 2023-12-31) — Working Capital: 219195000.00
TARS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 631000.00
TARS cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: 0.00
TARS cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
TARS cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
TARS cash_flow (quarterly, 2024-09-30) — Net Foreign Currency Exchange Gain Loss: 9000.00
TARS cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
TARS cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
TARS cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: -39000.00
TARS cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: 9000.00
TARS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 1240000.00
TARS balance_sheet (quarterly, 2024-09-30) — Raw Materials: 0.00
TARS income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
TARS income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
TARS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
TARS income_statement (annual, 2024-12-31) — +Operating Expense: 290696000.00
TARS income_statement (annual, 2024-12-31) — +Total Revenue: 182953000.00
TARS balance_sheet (annual, 2024-12-31) — Accounts Payable: 9419000.00
TARS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 46760000.00
TARS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1976000.00
TARS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 584559000.00
TARS cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 540000.00
TARS cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 540000.00
TARS cash_flow (annual, 2024-12-31) — Amortization Of Securities: -4213000.00
TARS income_statement (annual, 2024-12-31) — Basic Average Shares: 37604538.00
TARS income_statement (annual, 2024-12-31) — Basic EPS: -3.07
TARS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 224947000.00
TARS cash_flow (annual, 2024-12-31) — Capital Expenditure: -6567000.00
TARS balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 608000.00
TARS balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 608000.00
TARS balance_sheet (annual, 2024-12-31) — Capital Stock: 6000.00
TARS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 94819000.00
TARS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 291376000.00
TARS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 154656000.00
TARS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -199195000.00
TARS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -83027000.00
TARS cash_flow (annual, 2024-12-31) — Change In Account Payable: 2544000.00
TARS cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 2578000.00
TARS cash_flow (annual, 2024-12-31) — Change In Inventory: -2046000.00
TARS cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 572000.00
TARS cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 37560000.00
TARS cash_flow (annual, 2024-12-31) — Change In Payable: 2544000.00
TARS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 5122000.00
TARS cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -7019000.00
TARS cash_flow (annual, 2024-12-31) — Change In Receivables: -30345000.00
TARS cash_flow (annual, 2024-12-31) — Change In Working Capital: 3844000.00
TARS cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -30139000.00
TARS cash_flow (annual, 2024-12-31) — Changes In Cash: -127566000.00
TARS balance_sheet (annual, 2024-12-31) — Common Stock: 6000.00
TARS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 224534000.00
TARS cash_flow (annual, 2024-12-31) — Common Stock Issuance: 98287000.00
TARS income_statement (annual, 2024-12-31) — Cost Of Revenue: 12826000.00
TARS balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 48945000.00
TARS balance_sheet (annual, 2024-12-31) — Current Assets: 356705000.00
TARS balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 608000.00
TARS balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 608000.00
TARS balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 608000.00
TARS balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 608000.00
TARS balance_sheet (annual, 2024-12-31) — Current Liabilities: 80612000.00
TARS cash_flow (annual, 2024-12-31) — Depreciation: 685000.00
TARS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1225000.00
TARS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1225000.00
TARS income_statement (annual, 2024-12-31) — Diluted Average Shares: 37604538.00
TARS income_statement (annual, 2024-12-31) — Diluted EPS: -3.07
TARS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -115554000.00
TARS income_statement (annual, 2024-12-31) — EBIT: -108107000.00
TARS income_statement (annual, 2024-12-31) — EBITDA: -106882000.00
TARS cash_flow (annual, 2024-12-31) — End Cash Position: 97381000.00
TARS cash_flow (annual, 2024-12-31) — Financing Cash Flow: 154656000.00
TARS balance_sheet (annual, 2024-12-31) — Finished Goods: 2006000.00
TARS cash_flow (annual, 2024-12-31) — Free Cash Flow: -89594000.00
TARS cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 201000.00
TARS cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: -591000.00
TARS income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -792000.00
TARS income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 0.00
TARS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 179000.00
TARS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 8326000.00
TARS balance_sheet (annual, 2024-12-31) — Gross PPE: 4842000.00
TARS income_statement (annual, 2024-12-31) — Gross Profit: 170127000.00
TARS balance_sheet (annual, 2024-12-31) — Income Tax Payable: 0.00
TARS balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 0.00
TARS income_statement (annual, 2024-12-31) — Interest Expense: 7447000.00
TARS income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 7447000.00
TARS income_statement (annual, 2024-12-31) — Interest Income: 15014000.00
TARS income_statement (annual, 2024-12-31) — Interest Income Non Operating: 15014000.00
TARS cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 7662000.00
TARS balance_sheet (annual, 2024-12-31) — Inventory: 2620000.00
TARS balance_sheet (annual, 2024-12-31) — Invested Capital: 296379000.00
TARS cash_flow (annual, 2024-12-31) — Investing Cash Flow: -199195000.00
TARS balance_sheet (annual, 2024-12-31) — Investments And Advances: 3000000.00
TARS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 98287000.00
TARS cash_flow (annual, 2024-12-31) — Issuance Of Debt: 75000000.00
TARS cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
TARS balance_sheet (annual, 2024-12-31) — Leases: 794000.00
TARS balance_sheet (annual, 2024-12-31) — Long Term Debt: 71845000.00
TARS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 71845000.00
TARS cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 75000000.00
TARS cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
TARS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 2725000.00
TARS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 98287000.00
TARS income_statement (annual, 2024-12-31) — Net Income: -115554000.00
TARS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -115554000.00
TARS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -115554000.00
TARS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -115554000.00
TARS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -115554000.00
TARS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -115554000.00
TARS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -115554000.00
TARS cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -5000000.00
TARS cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: -5000000.00
TARS income_statement (annual, 2024-12-31) — Net Interest Income: 7165000.00
TARS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -192628000.00
TARS cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 75000000.00
TARS cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
TARS cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 75000000.00
TARS cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
TARS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 7165000.00
TARS cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -35400000.00
TARS cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 0.00
TARS balance_sheet (annual, 2024-12-31) — Net PPE: 2866000.00
TARS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1567000.00
TARS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 216208000.00
TARS income_statement (annual, 2024-12-31) — Normalized EBITDA: -104938000.00
TARS income_statement (annual, 2024-12-31) — Normalized Income: -113610000.00
TARS cash_flow (annual, 2024-12-31) — Operating Cash Flow: -83027000.00
TARS cash_flow (annual, 2024-12-31) — Operating Gains Losses: 2145000.00
TARS cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -598000.00
TARS income_statement (annual, 2024-12-31) — Operating Income: -120569000.00
TARS income_statement (annual, 2024-12-31) — Operating Revenue: 182953000.00
TARS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 38349826.00
TARS balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 18320000.00
TARS balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 18320000.00
TARS balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 179000.00
TARS income_statement (annual, 2024-12-31) — Other Income Expense: -2150000.00
TARS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1117000.00
TARS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 6094000.00
TARS income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -206000.00
TARS balance_sheet (annual, 2024-12-31) — Other Payable: 3320000.00
TARS balance_sheet (annual, 2024-12-31) — Other Properties: 1323000.00
TARS balance_sheet (annual, 2024-12-31) — Other Receivables: 1299000.00
TARS balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 196557000.00
TARS income_statement (annual, 2024-12-31) — Other Special Charges: 1944000.00
TARS income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
TARS balance_sheet (annual, 2024-12-31) — Payables: 12739000.00
TARS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 61684000.00
TARS balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
TARS balance_sheet (annual, 2024-12-31) — Prepaid Assets: 14650000.00
TARS income_statement (annual, 2024-12-31) — Pretax Income: -115554000.00
TARS cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 16769000.00
TARS balance_sheet (annual, 2024-12-31) — Properties: 0.00
TARS cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -5000000.00
TARS cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: -5000000.00
TARS cash_flow (annual, 2024-12-31) — Purchase Of Investment: -265628000.00
TARS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1567000.00
TARS balance_sheet (annual, 2024-12-31) — Raw Materials: 0.00
TARS balance_sheet (quarterly, 2024-12-31) — Raw Materials: 0.00
TARS balance_sheet (annual, 2024-12-31) — Receivables: 48059000.00
TARS income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 12826000.00
TARS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1225000.00
TARS income_statement (annual, 2024-12-31) — Research And Development: 53386000.00
TARS balance_sheet (annual, 2024-12-31) — Restricted Cash: 0.00
TARS balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 0.00
TARS balance_sheet (annual, 2024-12-31) — Retained Earnings: -360210000.00
TARS cash_flow (annual, 2024-12-31) — Sale Of Investment: 73000000.00
TARS income_statement (annual, 2024-12-31) — Selling General And Administration: 237310000.00
TARS balance_sheet (annual, 2024-12-31) — Share Issued: 38349826.00
TARS income_statement (annual, 2024-12-31) — Special Income Charges: -1944000.00
TARS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
TARS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 27818000.00
TARS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 224534000.00
TARS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 216208000.00
TARS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
TARS income_statement (annual, 2024-12-31) — Tax Provision: 0.00
TARS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
TARS balance_sheet (annual, 2024-12-31) — Total Assets: 376991000.00
TARS balance_sheet (annual, 2024-12-31) — Total Capitalization: 296379000.00
TARS balance_sheet (annual, 2024-12-31) — Total Debt: 72453000.00
TARS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 224534000.00
TARS income_statement (annual, 2024-12-31) — Total Expenses: 303522000.00
TARS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 152457000.00
TARS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 20286000.00
TARS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 71845000.00
TARS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -120569000.00
TARS income_statement (annual, 2024-12-31) — Total Other Finance Cost: 402000.00
TARS balance_sheet (annual, 2024-12-31) — Total Tax Payable: 0.00
TARS balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 0.00
TARS income_statement (annual, 2024-12-31) — Total Unusual Items: -1944000.00
TARS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
TARS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1944000.00
TARS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
TARS cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 591000.00
TARS balance_sheet (annual, 2024-12-31) — Work In Process: 614000.00
TARS balance_sheet (annual, 2024-12-31) — Working Capital: 276093000.00
TARS income_statement (quarterly, 2025-03-31) — +Operating Expense: 99404000.00
TARS income_statement (quarterly, 2025-03-31) — +Total Revenue: 78335000.00
TARS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 28383000.00
TARS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 62426000.00
TARS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2196000.00
TARS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 727697000.00
TARS cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 240000.00
TARS cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 240000.00
TARS cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -1314000.00
TARS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 39345359.00
TARS income_statement (quarterly, 2025-03-31) — Basic EPS: -0.64
TARS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 97381000.00
TARS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -590000.00
TARS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 384000.00
TARS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 6000.00
TARS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 175787000.00
TARS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 407916000.00
TARS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 136562000.00
TARS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -34942000.00
TARS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -20651000.00
TARS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 1144000.00
TARS cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -5890000.00
TARS cash_flow (quarterly, 2025-03-31) — Change In Inventory: -84000.00
TARS cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 125000.00
TARS cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 10165000.00
TARS cash_flow (quarterly, 2025-03-31) — Change In Payable: 1144000.00
TARS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -4746000.00
TARS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 8725000.00
TARS cash_flow (quarterly, 2025-03-31) — Change In Receivables: -16095000.00
TARS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1910000.00
TARS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -15666000.00
TARS cash_flow (quarterly, 2025-03-31) — Changes In Cash: 80969000.00
TARS balance_sheet (quarterly, 2025-03-31) — Common Stock: 6000.00
TARS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 342458000.00
TARS cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 135125000.00
TARS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 5211000.00
TARS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 53625000.00
TARS balance_sheet (quarterly, 2025-03-31) — Current Assets: 480773000.00
TARS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 384000.00
TARS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 384000.00
TARS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 86308000.00
TARS cash_flow (quarterly, 2025-03-31) — Depreciation: 220000.00
TARS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 460000.00
TARS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 460000.00
TARS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 39345359.00
TARS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.64
TARS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -25120000.00
TARS income_statement (quarterly, 2025-03-31) — EBIT: -23046000.00
TARS income_statement (quarterly, 2025-03-31) — EBITDA: -22586000.00
TARS cash_flow (quarterly, 2025-03-31) — End Cash Position: 178350000.00
TARS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 136562000.00
TARS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 1941000.00
TARS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -21241000.00
TARS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 85000.00
TARS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 8086000.00
TARS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 5376000.00
TARS income_statement (quarterly, 2025-03-31) — Gross Profit: 73124000.00
TARS income_statement (quarterly, 2025-03-31) — Interest Expense: 2074000.00
TARS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2074000.00
TARS income_statement (quarterly, 2025-03-31) — Interest Income: 3454000.00
TARS income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 3454000.00
TARS cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 2074000.00
TARS balance_sheet (quarterly, 2025-03-31) — Inventory: 2705000.00
TARS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 414442000.00
TARS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -34942000.00
TARS balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 3000000.00
TARS cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 135125000.00
TARS balance_sheet (quarterly, 2025-03-31) — Leases: 818000.00
TARS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 71984000.00
TARS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 71984000.00
TARS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 2741000.00
TARS cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 135125000.00
TARS income_statement (quarterly, 2025-03-31) — Net Income: -25120000.00
TARS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -25120000.00
TARS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -25120000.00
TARS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -25120000.00
TARS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -25120000.00
TARS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -25120000.00
TARS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -25120000.00
TARS income_statement (quarterly, 2025-03-31) — Net Interest Income: 1241000.00
TARS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -34352000.00
TARS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 1241000.00
TARS balance_sheet (quarterly, 2025-03-31) — Net PPE: 3180000.00
TARS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -590000.00
TARS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 334372000.00
TARS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -22586000.00
TARS income_statement (quarterly, 2025-03-31) — Normalized Income: -25120000.00
TARS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -20651000.00
TARS income_statement (quarterly, 2025-03-31) — Operating Income: -26280000.00
TARS income_statement (quarterly, 2025-03-31) — Operating Revenue: 78335000.00
TARS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 41995537.00
TARS balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 85000.00
TARS income_statement (quarterly, 2025-03-31) — Other Income Expense: -81000.00
TARS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 303000.00
TARS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 5711000.00